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compared toWishaw (p<0.05). There was no signiﬁcant difference in rates
of readmissions, A&E visits or reoperation (p>0.05). In patients with
complications, there was no signiﬁcant difference in their deprivation
status.
Conclusions: The ERP is a safe and effective protocol for breast surgery
patients with low complication rates and its implementation halved the
inpatient admission time in our cohort. The savings derived from this
would outweigh the running costs of the ERP.
0876: PREDICTORS OF LYMPH NODE METASTASIS IN LOCALLY
ADVANCED BREAST CANCER: WHAT TO DO WITH MICROMETASTASES?
Hannah Vaughan-Williams*, Michael Rees, Rory Kokelaar,
Pawel Pietrzsak, Louise Da Silva, Sumit Goyal. The Breast Centre,
Llandough Hospital, Cardiff, UK.
Introduction: Management of the axilla in breast cancer patients is
becoming increasingly complex. We assessed the surgical management of
breast cancer in a single centre and identiﬁed factors predictive of lymph
node metastasis.
Methods: A prospectively maintained database (January 2009 e
December 2011) was used to assess patients undergoing breast cancer
surgery involving axillary staging with Sentinel Lymph Node Biopsy
(SLNB). Primary outcomes were factors predictive of positive sentinel
lymph node at index procedure. Secondary outcomes were factors pre-
dictive of further lymph node metastases at subsequent axillary node
clearance (ANC).
Results: 456 female patients (age 29-90) were included, of whom 70
(15.4%) had at least one positive node at SLNB. Of these, 17 (32%) had
micrometastases alone while the remainder had evidence of macrometa-
stasis. 60 patients (85.7%) received ANC, of whom 18 (30%) had evidence of
further positive nodes. No patients with micrometastases alone at SLNB
had evidence of further positive nodes at ANC. On multivariate analysis,
factors predictive of positive SLNB were tumour size (p<0.01) and vascular
invasion (p<0.001). The only factor predicting further node involvement at
ANC was presence of macrometastasis at SLNB (p¼0.036).
Conclusions: Our results suggest that ﬁnding micrometastases alone at
SLNB may not necessitate ANC.
1057: IS THERE STILL A ROLE FOR BONE SCINTIGRAPHY IN PATIENTS
WITH BREAST CANCER SELECTED FOR SYSTEMIC STAGING IN THE ERA
OF MULTI-DETECTOR CT?
S.R. Tee*, D.P. McCartan, J. Rothwell, J. Geraghty, D. Evoy, C.M. Quinn,
R.S. Prichard, S. Skehan, A. O'Doherty, E.W. McDermott. St Vincents
University Hospital, Dublin, Ireland.
Introduction: Approximately 7% of women will have distant metastases
when presenting with breast cancer. The aim of this study was to evaluate
the additional diagnostic yield from bone scintigraphy in patients with
newly diagnosed breast cancer undergoing CT staging of the thorax,
abdomen and pelvis.
Methods: Patients with newly diagnosed breast cancer who underwent
systemic staging with CT-TAP and bone scintigraphy were included. Results
of biopsy and staging investigations were correlated. Criteria for staging
included: Locally advanced or inﬂammatory breast cancer, Neoadjuvant
therapy, Biopsy proven axillary nodal metastases on US axillary staging, Pa-
tients undergoing mastectomy, Symptoms suggestive of metastatic disease.
Results: 135 patients (median age 59) underwent systemic staging in
2012. Seventeen patients (13%) had distant metastases. Four patients (3%)
hadmetastases tomore than one organ on CT. Of the 13 (10%) patients with
one metastatic site, 2 (1%) had liver metastases and 5 (4%) had lung me-
tastases only. Six patients (4%) had bone metastases and only one of these
involved a bone (subtrochanteric femur) metastasis not seen on CT-TAP.
CT-TAP alone would have resulted in a false negative rate of 0.7%.
Conclusions: In patients with newly diagnosed breast cancer selected for
systemic staging, multi-detector CT is a satisfactory stand-alone in-
vestigation.
1098: THE ROLE OF TSG101 IN EXOSOMAL COMMUNICATION IN TRIPLE
NEGATIVE BREAST CANCER TUMOURS AND ITS POTENTIAL AS A
CHEMOTHERAPEUTIC TARGET
Shiva Sharma*,1, Luke Gubbins 1, Karolina Weiner-Gorzel 1,
Jeremy Simpson 3, Malcolm Kell 4, Amanda McCann 2. 1UCD, School ofMedicine and Medical Science, Dublin, Ireland; 2UCD, Conway Institute for
Biomolecular and Biomedical Research, Dublin, Ireland; 3UCD, School of Biology
and Environmental Science, Dublin, Ireland; 4Department of Surgery, Mater
Misericordiae University Hospital, Dublin, Ireland.
Introduction: TSG101 is an essential protein involved in the sorting and
trafﬁcking of cell components destined for cellular processing, degradation
or cellular release, and is integral to exosome production and release.
Exosomes have the ability to carry transcriptional information and transfer
information.
Results: BT-549 TNBC cells were more sensitive to the chemotherapeutic
drug Paclitaxel compared to MDA-MB-231 TNBC cells which were more
chemoresistant. Western Blot analysis demonstrated TSG101 levels were
higher in MDA-MB-231 and remained constant after 24 and 48 hours
treatment, while the more Paclitaxel sensitive BT-549 showed decreased
TSG101 levels, which decreased after 24 and 48 hours of Paclitaxel
treatment. Using a siRNA-knockdown of TSG101, NanoSight particle
analysis revealed the size and numbers of exosomes released by these
cell lines differed. Immunohistochemical analysis of 85 breast cancer
cases on TissueMicroArray established strong cytoplasmic staining of
TSG101 in 20% of cases, while 53% of tumours demonstrated none/weak
staining of TSG101.
Conclusions: We conclude that TSG101 is differentially expressed in the
TNBC in vitro and that expression levels are inﬂuenced by Paclitaxel
treatment, and siRNA-knockdown of TSG101 impedes the release of exo-
somes suggesting that high levels of TSG101 may provide a mechanism for
the dissemination of the malignant phenotype in recipient cells.
1113: WIDE LOCAL EXCISION UNDER LOCAL ANAESTHETIC FOR EARLY
BREAST CANCER: A SURGICAL OPTION FOR THE MEDICALLY UNFIT
Deepak Selvakumar*, Christopher Davies, Rahul Chotai,
Muhammad Asad Parvaiz, Brian Isgar. Department of Breast Surgery, New
Cross Hospital, The Royal Wolverhampton NHS Trust Hospitals,
Wolverhampton, UK.
Introduction: The mainstay of treatment for early breast cancer is surgery.
However for elderly and medically unﬁt patients treatment can be chal-
lenging. We look at the use of wide local excision (WLE) performed under
local anaesthetic (LA) compared to primary endocrine therapy (PET) in this
group of patients.
Methods: All breast cancer patients aged 50 and above, receiving non-
standard therapy (WLE under LA or PET), in the last 5 years were included.
We comparedmortality and follow-up times between these two treatment
groups.
Results: A total of 85 patients were seen, 26were included in theWLE under
LA group and 59 in the PET group. There was no signiﬁcant difference in
patient age (median age 85 and 83 respectively). Patients havingWLE under
LA had signiﬁcantly lower mortality (19%, p<0.05) and longer follow-up
time (35 months, p<0.05) compared to the PET group. The primary reason
for non-standard therapy in both groups was due to poor medical ﬁtness.
Conclusion: Selection to non-standard therapy should be made using a
combination of preoperative assessment and detailed discussion with
patients. Within this subset the use of WLE performed under LA can be a
successful treatment option for motivated patients with intact cognitive
function.
1125: EFFICACY OF POST-OPERATIVE PAIN CONTROL WITH THE HELP
OF PATIENT CONTROLLED WOUND SOAKERS (CONTINUOUS INFILTRA-
TION OF LOCAL ANAESTHETIC INFUSION) FOLLOWING BREAST RECON-
STRUCTION
Tom Pampiglione*, Khurram Siddique, Iman Azmy. Chesterﬁeld Hospital,
Chesterﬁeld, UK.
Introduction: Poor pain control following breast reconstruction has been
shown to increase the patient morbidity & the length of stay. Intravenous
narcotic analgesia has signiﬁcant side effects. To prospectively assess the
efﬁcacy of pain control with patient controlled wound soakers.
Methods: A prospective cross-sectional study including all breast re-
constructions with patient controlled wound soakers performed between
Apr12- Mar 13 was conducted.
Results: A total of 36 patients with the age of *49 (37-74) were included.
Procedures included expander/implant reconstructions with dermal sling
or Strattice 72%, LD ﬂaps 16% etc. Over 70% of patients experienced either
